TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$36.36-0.71%
Close 2026-09-04 · 1-day change
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · TEVA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | 14,104.0 | 17,258.0 | 16,544.0 | 15,846.0 | 14,925.0 | 15,878.0 | 16,659.0 | 16,887.0 | 18,271.0 | 20,314.0 | 20,317.0 | 18,312.0 | 16,121.0 | 16,121.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 20,314.0 | 20,317.0 | 18,312.0 | 16,121.0 | 16,121.0 |
| Cost of Revenues | 8,232.0 | 8,320.0 | 8,481.0 | 8,200.0 | 7,952.0 | 8,284.0 | 8,933.0 | 9,351.0 | 9,975.0 | 9,607.0 | 9,665.0 | 8,797.0 | 7,056.0 | 6,532.0 |
| Gross Profit | — | 8,938.0 | 8,064.0 | 7,645.0 | 6,973.0 | 7,594.0 | 7,726.0 | 7,537.0 | 8,296.0 | 10,707.0 | 10,652.0 | 9,515.0 | 9,065.0 | 7,367.0 |
| Operating Expenses & Income | ||||||||||||||
| R&D Expenses | — | — | — | — | 98.0 | — | — | 114.0 | 114.0 | 5.0 | — | — | — | — |
| Other Operating Expenses, Total | 19.0 | (18.0) | 14.0 | 49.0 | 107.0 | 98.0 | 40.0 | 76.0 | — | — | — | — | — | — |
| Operating Income | 1,604.0 | 2,157.0 | (303.0) | 433.0 | (2,197.0) | 1,716.0 | (3,572.0) | (443.0) | (1,637.0) | 1,649.0 | 2,205.0 | 3,109.0 | 3,871.0 | 2,405.0 |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | 916.0 | 1,002.0 | 1,029.0 | 930.0 | 891.0 | 901.0 | 822.0 | 920.0 | 314.0 | 355.0 | 234.0 | 202.0 | — |
| Interest & Investment Income | — | — | — | — | — | — | 104.0 | 41.0 | 39.0 | 32.0 | 26.0 | 44.0 | 57.0 | — |
| Net Interest Expenses | — | — | — | — | — | — | 797.0 | 781.0 | 881.0 | 282.0 | 329.0 | 190.0 | 145.0 | — |
| Other Non-Operating Income / Expenses | (897.0) | (934.0) | (981.0) | (1,057.0) | (966.0) | (1,058.0) | (834.0) | (822.0) | (959.0) | (399.0) | (386.0) | (153.0) | (225.0) | (202.0) |
| Asset Writedown | — | — | — | 1,078.0 | 2,447.0 | 584.0 | 6,546.0 | — | 5,621.0 | 524.0 | 1,071.0 | 201.0 | 124.0 | 110.0 |
| EBT, Incl. Unusual Items | 708.0 | 1,223.0 | (1,284.0) | (624.0) | (3,163.0) | 658.0 | (4,406.0) | (1,265.0) | (2,596.0) | 1,250.0 | 1,819.0 | 2,956.0 | 3,646.0 | 2,203.0 |
| Income Tax Expense | 12.0 | (180.0) | 676.0 | (7.0) | (643.0) | 211.0 | (168.0) | (278.0) | (195.0) | (43.0) | (137.0) | 127.0 | 283.0 | 166.0 |
| Net Income | ||||||||||||||
| Minority Interest | — | 7.0 | (320.0) | (56.0) | (53.0) | 39.0 | (109.0) | (2.0) | (322.0) | (16.0) | (53.0) | 9.0 | 8.0 | 4.0 |
| Net Income | 707.0 | 1,410.0 | (1,639.0) | (559.0) | (2,446.0) | 417.0 | (3,990.0) | (999.0) | (2,150.0) | 1,269.0 | 1,963.0 | 2,759.0 | 3,331.0 | 2,000.0 |
| Per Share | ||||||||||||||
| Basic EPS | 0.61 | 1.23 | (1.45) | (0.50) | (2.20) | 0.38 | (3.64) | (0.91) | (2.35) | 1.49 | 2.25 | 3.10 | 3.72 | 2.29 |
| Diluted EPS | 0.61 | 1.21 | (1.45) | (0.50) | (2.20) | 0.38 | (3.64) | (0.91) | (2.35) | 1.49 | 2.25 | 3.09 | 3.67 | 2.23 |
| Revenue per Share | 12.11 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | 0.00 | 0.00 | 1.28 | 1.03 | 0.89 | 0.74 | — |
| Basic Weighted Avg Shares | 1,165.0 | 1,145.0 | 1,131.0 | 1,119.0 | 1,110.0 | 1,102.0 | 1,095.0 | 1,091.0 | 1,021.0 | 849.0 | 872.0 | 890.0 | 896.0 | 872.0 |
| Diluted Weighted Avg Shares | 1,165.0 | 1,163.0 | 1,131.0 | 1,119.0 | 1,110.0 | 1,107.0 | 1,095.0 | 1,091.0 | 1,021.0 | 850.0 | 873.0 | 893.0 | 921.0 | 896.0 |
| Supplemental | ||||||||||||||
| EBITDA | — | 3,159.0 | 756.0 | 1,586.0 | (889.0) | 3,046.0 | (2,015.0) | 1,279.0 | 205.0 | 3,291.0 | 3,913.0 | 4,178.0 | 4,848.0 | 3,313.0 |
| EBIT | 1,604.0 | 2,157.0 | (303.0) | 433.0 | (2,197.0) | 1,716.0 | (3,572.0) | (443.0) | (1,637.0) | 1,649.0 | 2,205.0 | 3,109.0 | 3,871.0 | 2,405.0 |
| Effective Tax Rate | 1.7% | — | — | 1.1% | 20.3% | 32.1% | 3.8% | 22.0% | 7.5% | -3.4% | -7.5% | 4.3% | 7.8% | 7.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.